Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy

NCT01804712 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: rituximab

Sponsor

Christopher Kane

Collaborators

[object Object]